{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:54:26Z","timestamp":1672858466646},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,30]],"date-time":"2017-07-30T00:00:00Z","timestamp":1501372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bjid.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T23:15:20Z","timestamp":1510010120000},"page":"74-75","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?"],"prefix":"10.1016","volume":"22","author":[{"given":"Ethel L.","family":"Maciel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago N. do","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kleydson Bonfim","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.10.001_bib0050","series-title":"Secretaria de Vigil\u00e2ncia em sa\u00fade. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","author":"Minist\u00e9rio da Sa\u00fade (BR)","year":"2011"},{"key":"10.1016\/j.bjid.2017.10.001_bib0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1473-3099(13)70187-7","article-title":"Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial","volume":"13","author":"Durovni","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.001_bib0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciu849","article-title":"Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB\/HIV in Rio (THRio) study","volume":"60","author":"Golub","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.001_bib0065","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine\/isoniazid or dail rifampin\/pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bjid.2017.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.bjid.2017.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2017.10.001_bib0080","series-title":"Departamento de DST, Aids e Hepatites Virais. O Manejo da Infec\u00e7\u00e3o pelo HIV na Aten\u00e7\u00e3o B\u00e1sica: Manual para profissionais m\u00e9dicos","author":"Minist\u00e9rio da Sa\u00fade (BR)","year":"2015"},{"key":"10.1016\/j.bjid.2017.10.001_bib0085","first-page":"249","article-title":"Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil","volume":"15","author":"Saraceni","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.001_bib0090","unstructured":"Coordena\u00e7\u00e3o Geral do Programa Nacional de Controle da Tuberculose, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis, Minist\u00e9rio da Sa\u00fade. Of\u00edcio Circular no 25\/CGPNCT\/DEVIT\/SVS\/MS. Dificuldades na aquisi\u00e7\u00e3o do derivado proteico purificado \u2013 PPD. http:\/\/www.cve.saude.sp.gov.br\/htm\/TB\/eventos\/TB_OfCircular25_PPD.pdf [accessed 11.05.17]."}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T07:23:12Z","timestamp":1535268192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867017306967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1413867017306967"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.001","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}